研究显示一种AI助力研发的药物可能有抗衰老作用

智通财经
Sep 09
【研究显示一种AI助力研发的药物可能有抗衰老作用】英国学术期刊《自然-生物技术》日前刊登的一项国际研究成果显示,一种由人工智能驱动发现和设计、用于治疗特发性肺纤维化的候选药物,还可能具有潜在的抗衰老作用。由生物医药企业英硅智能、美国哈佛大学医学院等机构研究人员联合发表的论文说,研究团队分析了42名特发性肺纤维化患者在参加一项为期12周临床试验期间被采集的血清蛋白质组数据,发现接受药物Rentosertib治疗的患者体内一些与衰老相关的指标有改善,用于评估生物学年龄的“衰老时钟”降幅最高可接近6岁。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10